Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiome and mucosal environment represent a complex biological system comprising trillions of commensal microorganisms and the protective mucus layer of the intestinal tract. This ecosystem performs vital functions, including the fermentation of dietary fibers into short-chain fatty acids (SCFAs), synthesis of vitamins K and B12, and the regulation of the host's mucosal immune system (NIH, PMC3426293). The mucosal barrier serves as a critical interface, preventing the translocation of pathogens while allowing for nutrient absorption and signaling between the microbiota and the host (Nature Reviews Gastroenterology & Hepatology, 2014). Dysbiosis, or the functional imbalance of this ecosystem, is a key driver in the development of gastrointestinal disorders like Inflammatory Bowel Disease (IBD) and systemic conditions such as obesity and type 2 diabetes (PubMed, 24336217). Therapeutic interventions targeting this environment include antibiotics to eliminate pathogens, prebiotics to nourish beneficial bacteria, and live biotherapeutic products (LBPs) like SER-109 designed to restore ecological diversity (FDA, 2023). Unlike traditional single-molecule targets, modulating the gut microbiome requires a systems-biology approach to restore the complex interactions between microbial species and the host's epithelial and immune cells (Cell, 2019).
Restoration of microbial diversity, competitive exclusion of pathogens, modulation of host immune signaling through Toll-like receptors, and production of bioactive metabolites such as short-chain fatty acids (SCFAs) and bile acid derivatives.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiome and mucosal environment.